🇺🇸 FDA
Pipeline program

BEAM-201

BTX-ALO-001

Phase 2 mab active

Quick answer

BEAM-201 for Lymphoblastic Lymphoma is a Phase 2 program (mab) at Beam Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Beam Therapeutics
Indication
Lymphoblastic Lymphoma
Phase
Phase 2
Modality
mab
Status
active

Clinical trials